Low Cost Laser Diagnostic for CD4+ T Cell Counting

Information

  • Research Project
  • 7167700
  • ApplicationId
    7167700
  • Core Project Number
    R43AI070052
  • Full Project Number
    1R43AI070052-01A1
  • Serial Number
    70052
  • FOA Number
    PA-06-06
  • Sub Project Id
  • Project Start Date
    7/15/2006 - 19 years ago
  • Project End Date
    6/30/2007 - 18 years ago
  • Program Officer Name
    LIVNAT, DANIELLA
  • Budget Start Date
    7/15/2006 - 19 years ago
  • Budget End Date
    6/30/2007 - 18 years ago
  • Fiscal Year
    2006
  • Support Year
    1
  • Suffix
    A1
  • Award Notice Date
    7/12/2006 - 19 years ago

Low Cost Laser Diagnostic for CD4+ T Cell Counting

[unreadable] DESCRIPTION (provided by applicant): Precision Photonics Corporation proposes to develop and demonstrate the key technologies for a laser based diagnostic system for CD4+ T-cell counting in human blood. The ultimate goal is to provide very low cost, easy to use tests at the point of care to help in assessment of disease status of AIDS patients in resource limited settings. The technology will use novel diode laser illumination and ultra-sensitive detection techniques with low cost optics and lasers, analogous to a DVD sensor head. By combining sensitive detection with an immunoassay format, reagent consumption is minimized. A 2-color detection system capable of discriminating CD4+ T cells from total T cells captured on a covalently-coupled MAb grid will be developed. In the proposed project, the specific aims are to (i) develop a T cell-specific capture immunoassay on a grid, with dual label fluorescence to discriminate CD4+ from total T cells, (ii) adapt a compact diode laser imaging immunosensor platform for 2-color detection and automated cell counting, and (iii) perform proof-of-principle experiments comparing our detection method to flow cytometry, using characterized samples from collaborators. Analysis and cell counting is performed electronically, with a simple numerical readout showing both the CD4+ T cell count and CD4+ T cell percentage. The simplicity and low cost will facilitate the use of anti-retroviral therapy in resource limited settings. An internationally recognized clinical team has been assembled to take the technology into clinical trials in Phase 2. The research performed in this project, if successful, will enable very low cost, easy to use tests at the point of care to help in assessment of disease status of AIDS patients in resource limited settings. The simplicity and low cost of the technology will facilitate the use of anti-retroviral therapy, greatly prolonging the lives of those infected with HIV and reducing the burden of disease in populations where HIV is endemic. [unreadable] [unreadable] [unreadable]

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    86063
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
    NIAID:86063\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PRECISION PHOTONICS CORPORATION (PPC)
  • Organization Department
  • Organization DUNS
    112617480
  • Organization City
    BOULDER
  • Organization State
    CO
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    80301
  • Organization District
    UNITED STATES